Spontaneous Spinal Epidural Haematoma Following COVID-19 Vaccination: a Case Report
Overview
Authors
Affiliations
Introduction: COVID-19 vaccination side effects are rare but important medical situations. Spine-affecting side effects are amongst the rarest, but exceedingly important. Haemorrhagic spinal manifestations of COVID-19 and its vaccines are less reported with little knowledge about them.
Case Presentation: An 80-year-old male who received his first shot of the COVID-19 vaccine had developed COVID-19 pneumonia, weakness, and sensory problems in his legs followed by sphincter incontinence within 5 days period. MRI showed a spontaneous epidural spinal epidural haematoma (SSEDH) in T10-L1. He underwent laminectomy and haematoma evacuation. One month follow-up showed no clinical improvement.
Discussion: To our knowledge, this was the first post-vaccination SSEDH and second in haemorrhagic spinal complications following COVID-19 vaccination. Considering the neuropathogenesis pathway of COVID-19 and its vaccines, there are common mechanisms of action that could potentially justify post-vaccination SSEDH such as seen in COVID-19 infection, itself. Early Neurosurgical intervention and better preoperative neurological status could be a beneficial modifier for favourable clinical outcomes.
Conclusion: SSEDH and COVID-19 vaccine coincidence is a rare clinical event, still no solid association could be scientifically explained. Further studies are required for a reliable pathophysiologic association. Early diagnosis, interdisciplinary medical approach, and faster intervention are the cornerstone of the treatment paradigm.
Spontaneous Spinal Epidural Hematoma During Pregnancy: A Case Report.
Yilmaz M, Aydin K Cureus. 2024; 16(11):e72971.
PMID: 39634995 PMC: 11616223. DOI: 10.7759/cureus.72971.
Ibrahim B, Al-Khawaldeh M, Abu Sirhan L, Arabyat A, Abdallah R, Hiasat M Cureus. 2024; 16(8):e66283.
PMID: 39108771 PMC: 11302480. DOI: 10.7759/cureus.66283.
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination.
Panos L, Bargiotas P, Hadjigeorgiou G, Panos G Drug Des Devel Ther. 2024; 18:1891-1905.
PMID: 38836116 PMC: 11147783. DOI: 10.2147/DDDT.S464394.